Yoshihiro Takai - Concepedia

Author

Yoshihiro Takai

Tohoku University

Also Known As

Akihiro Ito, Naoko Nakahata, Shuichi Ono, Y Takai, YOSHIHIRO TAKAI, Yoshihiro TAKAI, Yoshihiro Takai

227

Publications

Citations

H-Index

133

Concepts

All Affiliations

Tohoku University Hirosaki University Southern Tohoku General Hospital Kyoto University Hiroshima University

About

Yoshihiro Takai is an author at Tohoku University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	3.6K
2	Health Sciences	19	27	2.3K
3	Engineering	7	7	378
4	Public Health	2	2	97
5	Social Sciences	2	2	85

Yoshihiro Takai

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study Hiroshi Onishi, Hiroki Shirato, Yasushi Nagata, Journal of Thoracic Oncology Radiation TherapyMedicineJapanese Multi-institutional StudyClinical Radiation OncologyOncology	2007	969
Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma Hiroshi Onishi, Tsutomu Araki, Hiroki Shirato, Cancer	2004	902
Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery? Hiroshi Onishi, Hiroki Shirato, Yasushi Nagata, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNon–small-cell Lung CancerRadiation MedicineSurgical OncologyRadiation Therapy	2010	611
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403 Yasushi Nagata, Masahiro Hiraoka, Taro Shibata, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyBoth OperableMedicineProspective Trial	2015	439
Renewable resource based biocomposites from natural fiber and polyhydroxybutyrate-co-valerate (PHBV) bioplastic S. P. Singh, Amar K. Mohanty, Tomohiko Sugie, Composites Part A Applied Science and Manufacturing Renewable ResourceBiomanufacturingBioplasticsBioenergyEngineering	2008	237
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial Katsumi Hirose, Akiyoshi Konno, Junichi Hiratsuka, Radiotherapy and Oncology	2020	227
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer Masashi Koto, Yoshihiro Takai, Yoshihiro Ogawa, Radiotherapy and Oncology Adaptive RadiotherapyCell Lung CancerRadiation TherapyMedicinePhase Ii Study	2007	172
Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma Hiroyasu Yasuda, Katsutoshi Nakayama, Mika Watanabe, Clinical Cancer Research	2006	117
Age-associated increase of spontaneous mutant frequency and molecular nature of mutation in newborn and old lacZ-transgenic mouse Tetsuya Ono, Hironobu Ikehata, Shingo Nakamura, Mutation research. Fundamental and molecular mechanisms of mutagenesis Knockout MouseSomatic VariantTransgenic Mouse ModelsGenetic DisorderSpontaneous Mutant Frequency	2000	89
Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Keith R. Britton, Yoshihiro Takai, Masatoshi Mitsuya, PubMed	2005	85

Page 1